Explore more publications!

Elections Post Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Elections Post Observer.

Press releases published on January 21, 2026

Javier Palomarez, USHBC President & CEO, Responds to President Trump’s Immigration Enforcement Prioritization Remarks
New York’s Congestion Pricing Marks a Turning Point for Urban Mobility
Raluca Niță Discusses Emerging Shifts in U.S.–Europe Security Expectations
New Research on AI Tools for Special Education Advocacy Emphasizes Transparency, Workflow Fit, and Trust
The European Releases Its Residence & Citizenship Planning Supplement
Stand Up For Science Statement on FY2026 Science Appropriations
Nebraska Insurance Professional and Policy Author Lee Benham Announces Intent to Explore U.S. Senate Run as a Democrat
E-novation Foundation Launches U.S. Mission in Partnership with International Reputation Institute
Alona Lebedieva: the case of Ukrzaliznytsia as the limit of the old model of state infrastructure
AMERICAN REBEL HOLIDNGS, INC. (NASDAQ: AREB) ANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT WITH ROUND LOT SHAREHOLDER PROTECTION TO BE EFFECTIVE ON FEBRUARY 2, 2026, FOR ALL SHAREHOLDERS OF RECORD AS OF THE EFFECTIVE DATE
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
Nyxoah Investit Dans l'Expansion De Sa Capacité De Production En Belgique Afin De Soutenir Sa Croissance Mondiale
Archbishop Angaelos contributes to CSI essay series on 'Persecution and the unity of believers'
Pharmacist and Pharmacy Organizations Including NASP Commend 2026 Spending Bill with Important PBM Provisions, Urge Passage
HII Completes Builder’s Sea Trials for USS Zumwalt (DDG 1000)
Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process
OFL: Labour Leaders Demand Immediate Action on Outstanding Bill 124 Remedies
Transaction in Own Shares
Burn Pits 360 Releases Spanish Version  of Military Toxic Exposure Guide
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions